Climb Bio (CLYM) EBIT (2020 - 2026)
Climb Bio (CLYM) posted EBIT of -$15.2 million for Q1 2026, up 21.17% on a QoQ basis from -$19.3 million in Q4 2025, and up 33.92% year-over-year from -$11.4 million in Q1 2025.
Climb Bio (CLYM) EBIT (2020 - 2026) Analysis & Trends
Climb Bio's EBIT history runs 7 years deep, the most recent figure standing at -$15.2 million for Q1 2026.
- Quarterly EBIT rose 33.92% year-over-year to -$15.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60.1 million (up 41.12% YoY) and the FY2025 annual result came in at -$67.9 million, up 17.24% from the prior year.
- EBIT was -$15.2 million for Q1 2026 at Climb Bio, up from -$19.3 million in the prior quarter.
- Across five years, EBIT topped out at -$3.0 million in Q1 2024 and bottomed at -$56.4 million in Q2 2024.
- A 5-year average of -$14.7 million and a median of -$11.7 million in 2024 frame the typical range for EBIT.
- Peak annual rise in EBIT reached 87.18% in 2024, while the deepest fall reached 739.62% in 2024.
- Climb Bio's EBIT stood at -$9.6 million in 2022, then jumped by 46.39% to -$5.1 million in 2023, then sank by 113.02% to -$10.9 million in 2024, then plunged by 76.85% to -$19.3 million in 2025, then increased by 21.17% to -$15.2 million in 2026.
- Business Quant data shows CLYM's EBIT at -$15.2 million in Q1 2026, -$19.3 million in Q4 2025, and -$14.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Climb Bio | 875.44 Mn | 875.44 Mn | - | -15.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.21 Mn |
| Dec 31, 2025 | -19.30 Mn |
| Sep 30, 2025 | -14.89 Mn |
| Jun 30, 2025 | -10.68 Mn |
| Mar 31, 2025 | -23.02 Mn |
| Dec 31, 2024 | -10.91 Mn |
| Sep 30, 2024 | -11.73 Mn |
| Jun 30, 2024 | -56.37 Mn |
| Mar 31, 2024 | -3.01 Mn |
| Dec 31, 2023 | -5.12 Mn |
| Sep 30, 2023 | -5.00 Mn |
| Jun 30, 2023 | -6.71 Mn |
| Mar 31, 2023 | -23.44 Mn |
| Dec 31, 2022 | -9.55 Mn |
| Sep 30, 2022 | -8.75 Mn |
| Jun 30, 2022 | -13.70 Mn |
| Mar 31, 2022 | -13.13 Mn |
| Dec 31, 2021 | -10.70 Mn |
| Sep 30, 2021 | -9.38 Mn |
| Jun 30, 2021 | -8.71 Mn |